(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MOLOGRAM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MOLOGRAM

ST13

US500000079342777

Classe

1, 5, 9, 10

Pedido

79342777

Registro

7282233

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

13/05/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 10

Data de depósito

01/04/2022

Data de registro

23/01/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/01/2024

Última transação

23/01/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

25

Localização do titular

CH

Examinador

GAGLIARDI, JEANINE

Unidade examinadora

N20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

lino Biotech AG

Representantes

Joyce von Natzmer Agris & von Natzmer LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Diagnostic preparationsother than for medical or veterinary purposes; chemical and biochemical test kits for detection of molecular interactions and characterization of drug candidates for laboratory analysesother than for medical or veterinary purposes; biological and chemical compounds and compositions and reagents being chemical test kits for detection of molecular interactions and characterization of drug candidates for laboratory analysesother than for medical or veterinary purposes

Classe 5

Diagnostic preparations for medical or veterinary purposes; in-vitro diagnostic preparations for medical use; test kits for detecting biomarkers for medical diagnostic purposes comprised of medical diagnostic reagents and assays for testing of body fluids for use in disease detectiondetection of genetic diseasescancerdiseases being amenable to cell and gene therapy; diagnostic agentspreparationssubstances for medical purposesbiological and chemical agents and compositions and reagents for use in test kits for detecting biomarkers for medical diagnostic purposes; reagents for use in diagnostic tests for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes

Classe 9

Diagnostic devices and apparatus for scientific use being chip holdersfluorescence readersliquid handling apparatus for scientific use; sensorsdetectors and monitoring instruments and apparatusoptical sensorsphotodiodesphototransistorsphotoresistorslaser sensorslight intensity meterslight defraction detectorslight refraction detectorsposition sensing detectors (PSD)charged-coupled devices (CCD); biosensors and biochip sensors being sensor chips for scientific use; chemical sensors being sensors for measuring chemical levels in aqueous solutions not for medical use; optical sensors; sensor controllers being electronic controllers for operating the aforementioned sensors

Classe 10

Diagnostic apparatus for medical purposes for detecting genetic diseasescancerdiseases being amenable to cell and gene therapy; medical apparatus and instruments for conducting diagnostic tests for medical purposesapparatus for medical diagnostic testing in the fields of cell-based and molecule-based testing; sensor apparatus for medical use in diagnosis being biofeedback sensors; diagnostic apparatus and instruments for use in test processes for detecting biomarkers for medical diagnostic purposes being medical diagnostic apparatus for testing for genetic diseasescancerdiseases being amenable to cell and gene therapy

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

13/05/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

24/04/2024

FIMP

FINAL DISPOSITION PROCESSED

24/04/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

23/04/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

23/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

23/01/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

11/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

22/11/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

22/11/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/11/2023

PUBO

PUBLISHED FOR OPPOSITION

07/11/2023

GPNX

NOTIFICATION PROCESSED BY IB

06/11/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

18/10/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

18/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

18/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/09/2023

RFNT

REFUSAL PROCESSED BY IB

13/04/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

17/03/2023

RFRR

REFUSAL PROCESSED BY MPU

17/03/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

25/01/2023

CNRT

NON-FINAL ACTION WRITTEN

24/01/2023

DOCK

ASSIGNED TO EXAMINER

19/01/2023

MAFR

APPLICATION FILING RECEIPT MAILED

21/06/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

17/06/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

16/06/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MOLOGRAM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.